Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amylin-Induced Migraine Attacks Without Aura
NCT07340788Not yet recruiting
- Sponsor
- Dansk Hovedpinecenter
- Start
- Feb 2026
- Primary completion
- Oct 2028
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of pramlintide in migraine without aura (2 arms), sponsored by Dansk Hovedpinecenter. Primary endpoint: Incidence of migraine attacks without aura at 12 hours. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
pramlintide
03
Conditions
migraine without aura
Beyond the preview
Go deeper on NCT07340788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07340788.